BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ProTron Technologies, Inc.'s Cerebral Stethoscope Offers Breakthrough for Early Detection of Aneurysms


7/16/2012 10:49:29 AM

ALPINE, N.J., July 13, 2012 /PRNewswire/ -- ProTron Technologies has developed a breakthrough diagnostic apparatus for detecting cerebro-vasacular diseases such as aneurysms or atherosclerotic plaque. The patented Stethotron® Cerebral Stethoscope is the physician's first line of defense against ruptured aneurysms.

"Prevention is the best cure," says Dr. Leon Dondysh, inventor of the Cerebral Stethoscope. "Atherosclerotic plaque, the narrowing of blood vessels, causes audible turbulence in the bloodstream. We have created the Stethotron® Cerebral Stethoscope as an intra-vascular atherosclerotic detector."

Unlike ultrasound, the cerebral stethoscope is non-invasive and avoids listening to undesirable wavelengths. Using ProTron's patented filtration, doctors may detect the audible, vascular turbulence that reveals pathology, eliminating the cost of ultrasound, and in only minutes.

Without invasive procedures, doctors can now quickly and easily detect early aneurysms and atherosclerotic changes in vessels before more acute symptoms appear, when it is too late and too costly to treat.

Image: http://www.ereleases.com/pic/Stethotron.jpg

For more information and purchasing options, please visit us on the web:

http://www.Stethotron.com
http://cerebralstethoscope.com/#

Contact:

Dr. Leon Dondysh
ProTron Technologies
PO BOX 234
Alpine, NJ 07620
info@Stethotron.com
Phone: 201-297-7377

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

SOURCE ProTron Technologies



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES